Login / Signup

Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors.

Sho IketaniFarhad ForouharHengrui LiuSeo Jung HongFang-Yu LinManoj S NairArie ZaskYaoxing HuangLi XingBrent R StockwellAlejandro ChavezDavid D Ho
Published in: Nature communications (2021)
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus